Investors were very bullish after the report as the stock price jumped over 20%. Yellow flags are not a reason to sell but just things to consider as an investor. Affirm reported solid year-over-year revenue growth, but the most significant bullish case for investors is the guidance for the fiscal year 2022. Read More...
Motley Fool
5 Top Stocks for September
If the September Effect hits us again this year, our contributors have five stocks to suggest that you could pick up at a discount: Insulet (NASDAQ: PODD), Amazon (NASDAQ: AMZN), Shopify (NYSE: SHOP), Cresco Labs (OTC: CRLBF), and PubMatic (NASDAQ: PUBM). Medtronic and Tandem Diabetes were the first companies to offer next-generation, automated insulin delivery systems, but stiff competition from Insulet’s Omnipod 5 could be coming soon.
Add Comment